Manage subscriptions


You can follow the discussion on Mylan calls Allergan’s patent deal with Indian tribe a “sham” transaction in PTAB hearing on sovereign immunity defense without having to leave a comment. Cool, huh? Just enter your email address in the form here below and you’re all set.